<\/p>\n
Admenta<\/strong> egy Sun Pharma \u00e1ltal gy\u00e1rtott tabletta, amely tartalmazza memantine 5 mg<\/strong> \u2014 egy uncompetitive NMDA receptor antagonist<\/strong> used for the symptomatic treatment of moderate-to-severe Alzheimer's disease<\/strong>. Memantine is nem<\/strong> indicated for mild Alzheimer's. Slow upward titration over 4 weeks: 5 mg week 1, 10 mg week 2 (5 mg twice daily), 15 mg week 3, 20 mg week 4 onwards (10 mg twice daily)<\/strong>. Generally well tolerated — main side effects are dizziness, headache, constipation and confusion. Reduce dose if eGFR < 30 mL\/min<\/strong>. Often combined with donepezil in moderate-to-severe disease for additive cognitive benefit.<\/p>\n<\/div>\n \ud83d\udce6 Minden rendel\u00e9st fedez a \u00dajrak\u00fcld\u00e9si Garancia<\/strong><\/a> \u2014 ha a csomagod nem \u00e9rkezik meg 20 munkanapon bel\u00fcl, \u00fajrak\u00fcldj\u00fck.<\/p>\n Generikus gy\u00f3gyszereink WHO-GMP min\u0151s\u00edt\u00e9s\u0171 gy\u00e1rt\u00f3kt\u00f3l sz\u00e1rmaznak, \u00e9s diszkr\u00e9t, egyszer\u0171 csomagol\u00e1sban sz\u00e1ll\u00edtjuk \u0151ket vil\u00e1gszerte \u2014 a csomagon nem szerepel a gy\u00f3gyszer neve. A k\u00e1rty\u00e1s fizet\u00e9sek egy szab\u00e1lyozott feldolgoz\u00f3n kereszt\u00fcl t\u00f6rt\u00e9nnek (a sz\u00e1mlale\u00edr\u00e1sok egy szab\u00e1lyozott k\u00e1rtyafizet\u00e9si feldolgoz\u00f3t tartalmaznak \u2014 soha nem \u201cMedsBase\u201d vagy b\u00e1rmilyen gy\u00f3gyszer neve). Kriptovalut\u00e1t \u00e9s SEPA banki \u00e1tutal\u00e1st is elfogadunk. Minden rendel\u00e9st a Reshipment Assurance Policy biztos\u00edt\u00e9k fedez.<\/p>\n Admenta is an oral tablet from Sun Pharma containing memantine hydrochloride 5 mg<\/strong>. Memantine is a low-affinity, voltage-dependent, uncompetitive antagonist of the N-methyl-D-aspartate (NMDA) glutamate receptor<\/strong>. It is mechanistically distinct from the cholinesterase inhibitors (donepezil, galantamine, rivastigmine) and works through the second major pathway implicated in Alzheimer's disease — glutamate excitotoxicity.<\/p>\n Admenta from Sun Pharma is a 5 mg memantine tablet — the strength used during the mandatory 4-week up-titration to the 20 mg\/day maintenance dose. Maintenance dosing is two 5 mg tablets twice daily (4 tablets total per day). Memantine is licensed only for moderate-to-severe Alzheimer's disease<\/strong> — not mild. It is the standard add-on to a cholinesterase inhibitor (typically donepezil) when patients progress past the mild stage, and produces additive cognitive and functional benefit with minimal increase in side effects.<\/p>\n Alzheimer's disease causes chronic excessive glutamate signalling at NMDA receptors — a process called glutamate excitotoxicity<\/strong>. Constant low-level NMDA activation damages neurons and disrupts the signal-to-noise ratio that the brain needs for learning and memory. Memantine addresses this through a unique mechanism:<\/p>\n Onset of cognitive benefit: visible at 4\u201312 h\u00e9t<\/strong> after reaching the maintenance 20 mg\/day dose; peak benefit at 6 months.<\/p>\n Admenta is nem<\/strong> indik\u00e1ci\u00f3i: mild Alzheimer's disease<\/strong> (cholinesterase inhibitors are first-line at this stage), mild cognitive impairment without dementia, frontotemporal dementia, or as a cognitive enhancer in healthy adults.<\/p>\n Admenta comes at 5 mg<\/strong> tablets. The titration schedule is mandatory — jumping straight to 20 mg\/day causes intolerable confusion and dizziness in most patients.<\/p>\n Standard 4-week titration:<\/strong><\/p>\n Common (worst during titration, settle once on maintenance):<\/strong><\/p>\n Kevesebb gyakoris\u00e1ggal:<\/strong><\/p>\n Rare but seek medical review:<\/strong><\/p>\nMi\u00e9rt rendelj a MedsBase-r\u00f3l<\/h3>\n
What Is Admenta?<\/h2>\n
How Does Admenta Work?<\/h2>\n
\n
Felhaszn\u00e1l\u00e1s \u00e9s indik\u00e1ci\u00f3k<\/h2>\n
\n
Admenta Dosage and How to Take — SLOW TITRATION<\/h2>\n
\n
How to Take Admenta Properly<\/h3>\n
\n
Side Effects of Admenta<\/h2>\n
\n
\n
\n
Figyelmeztet\u00e9sek \u00e9s el\u0151vigy\u00e1zatoss\u00e1g<\/h2>\n
\n
Contraindications — Who Should NOT Take Admenta<\/h2>\n
\n
Gy\u00f3gyszerk\u00f6lcs\u00f6nhat\u00e1sok<\/h2>\n